Olympus Aktie
10,73EUR | 0,39EUR | 3,77% |
WKN: 856840 / ISIN: JP3201200007
Personal
2021 | 2022 | 2023 | 2024 | 2025 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 31 653 | 31 557 | 32 844 | 28 838 | 29 297 |
Umsatz pro Mitarbeiter in Mio. EUR | 23,08 | 27,53 | 26,85 | 32,46 | 34,04 |
Bilanz (in Mio. JPY) - Aktiva
2021 | 2022 | 2023 | 2024 | 2025 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 580 162 | 694 605 | 726 357 | 800 340 | 679 443 |
Summe Anlagevermögen | 600 855 | 663 394 | 781 951 | 733 876 | 753 383 |
Summe Aktiva | 1 181 017 | 1 357 999 | 1 508 308 | 1 534 216 | 1 432 826 |
Bilanz (in Mio. JPY) - Passiva
2021 | 2022 | 2023 | 2024 | 2025 | |
---|---|---|---|---|---|
Summe Fremdkapital | 785 537 | 846 637 | 867 074 | 777 030 | 681 093 |
Summe Eigenkapital | 395 480 | 511 362 | 641 234 | 757 186 | 751 733 |
Summe Passiva | 1 181 017 | 1 357 999 | 1 508 308 | 1 534 216 | 1 432 826 |
Adresse
2951 Ishikawa-cho, 192-8507 Hachioji | |
Telefon | +81 (42) 642-2111 |
Internet | http://www.olympus.co.jp |
Management
Boris Shkolnik
Chief Quality Officer & Executive Officer |
David Robert Hale
Independent Outside Director |
Frank Drewalowski
Executive Officer & Head-Gastrointestinal Solution |
Gabriela Castillo Kaynor
Chief Strategy Officer & Executive Officer |
Gary John Pruden
Independent Outside Director |
Hiroshi Ishino
Independent Outside Director |
Jimmy C. Beasley
Independent Outside Director |
John de Csepel
Chief Medical Officer & Executive Officer |
Kohei Kan
Independent Outside Director |
Luann Marie Pendy
Independent Outside Director |
Masato Iwasaki
Independent Outside Director |
Neil Boyden Tanner
Executive Officer & Global General Counsel |
Robert White
President, CEO & Representative Director |
Sachiko Ichikawa
Independent Outside Director |
Seiji Kuramoto
Chief Surgical Intervention Business Officer |
Shigeto Ohtsuki
Chief Human Resources Officer & Executive Officer |
Stephen Mark Kneebone
Chief Information Officer & Executive Officer |
Syed Naveed
Chief Technology Officer & Executive Officer |
Takaaki Sakurai
Vice President-Investor Relations |
Takayuki Aoyagi
Vice President-Accounting |
Tatsuya Izumi
Chief Financial Officer & Executive Officer |
Tetsuaki Mori
Head-Research & Development Strategy |
Tetsuo Kobayashi
Chief Manufacturing & Supply Officer |
Tomohisa Sakurai
Executive Officer & Head-Government Affairs |
Toshihiko Okubo
Director |
Tsuyoshi Ogura
Deputy Chief Quality Regulatory Officer |
Yasuo Takeuchi
Chairman & ESG Officer |